Conference Call Cipher will hold a conference call on March 15, 2024, at 8:30 a.m. (ET) to discuss its financial results and other corporate developments.
- To access the conference call by telephone, dial (416) 764-8650 or (888) 664-6383 and use conference ID 08128854
- A live audio webcast will be available at https://app.webinar.net/YqROVOGVJeP
- An archived replay of the webcast will be available until March 22, 2024 and can be accessed by dialing (416) 764-8677 or (888) 390-0541 and entering conference replay code 128854#
About Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals (TSX: CPH) (OTCQX: CPHRF) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products either directly in Canada or indirectly through partners in Canada, the U.S., and South America. For more information, visit www.cipherpharma.com.